CAJ | 학술논문

目的：探讨食管癌新辅助同步放化疗后的最佳手术时机。方法：选择于2009年1月-2012年12月进行新辅助同步放化疗的85例食管癌手术患者，将其分为放化疗后3周的观察组，放化疗后6周的对照组，比较两组术中出血量、手术时间、围手术期的并发症。结果：平均淋巴结清除的个数、切缘阳性率、手术时间、术后并发症、术后平均恢复时间，两组相比差异无显著性意义（P＞0．05）。结论：两组不同手术时机的食管癌新辅助同步放化疗后的围手术期疗效相当。放化疗后3周手术组，患者依从性更好，术后如需辅助治疗可尽早进行，远期疗效有待进一步观察。
목적：탐토식관암신보조동보방화료후적최가수술시궤。방법：선택우2009년1월-2012년12월진행신보조동보방화료적85례식관암수술환자，장기분위방화료후3주적관찰조，방화료후6주적대조조，비교량조술중출혈량、수술시간、위수술기적병발증。결과：평균림파결청제적개수、절연양성솔、수술시간、술후병발증、술후평균회복시간，량조상비차이무현저성의의（P＞0．05）。결론：량조불동수술시궤적식관암신보조동보방화료후적위수술기료효상당。방화료후3주수술조，환자의종성경호，술후여수보조치료가진조진행，원기료효유대진일보관찰。
Objective :To investigate the optimal timing of surgery for esophageal cancer after neoadjuvant concurrent chemoradiotherapy.Methods :85 cases of esophageal cancer patients underwent neoadjuvant concurrent chemoradiother-apy from January 2009 to December 2012 had been into group ,divided into observation group after neoadjuvant concur-rent chemoradiotherapy three weeks ,six weeks after neoadjuvant concurrent chemoradiotherapy in the control group . Then the intraoperative blood loss ,operation time ,incidence of complications were analyzed .Results:There was no sig-nificant difference (P>0 .05) .Conclusion:The perioperative efficacy of the two different timing of surgery for esopha-geal cancer after neoadjuvant concurrent chemoradiotherapy has no significant difference .In the observation group ,pa-tients have better compliance ,and the adjuvant treatment can be carried out as soon as possible ,the long-term efficacy remains to be seen .